JPMorgan Chase & Co. Reiterates "Overweight" Rating for Bridgepoint Group (LON:BPT)

Bridgepoint Group (LON:BPT - Get Free Report)'s stock had its "overweight" rating restated by stock analysts at JPMorgan Chase & Co. in a research report issued on Friday, Marketbeat Ratings reports.

Separately, Citigroup upgraded Bridgepoint Group to a "buy" rating and set a GBX 410 ($5.58) price objective for the company in a research report on Thursday, March 20th.

Bridgepoint Group Trading Up 0.9%

Shares of BPT stock traded up GBX 2.93 ($0.04) during mid-day trading on Friday, reaching GBX 324.03 ($4.41). 216,211 shares of the stock traded hands, compared to its average volume of 2,043,365. The stock's fifty day simple moving average is GBX 289.19 and its two-hundred day simple moving average is GBX 318.67. Bridgepoint Group has a 1-year low of GBX 229.20 ($3.12) and a 1-year high of GBX 410 ($5.58). The company has a market cap of £2.68 billion, a price-to-earnings ratio of 58.86, a price-to-earnings-growth ratio of 0.61 and a beta of 1.72. The company has a quick ratio of 3.60, a current ratio of 4.98 and a debt-to-equity ratio of 12.89.

Bridgepoint Group Company Profile

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.